|
Market Closed -
London S.E.
09:05:29 11/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 11,708.00 GBX | -0.43% |
|
-2.48% | -15.10% |
| 12/09 | AstraZeneca Says Late-Stage Etcamah Breast-Cancer Trial Misses Main Goal | MT |
| 12/09 | AstraZeneca's breast cancer pill fails in late-stage trial | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.43% | -2.48% | -1.15% | -13.77% | -15.10% | -2.07% | +11.48% | +43.25% | +142.95% | 25TCr | |
| -0.65% | -2.93% | -8.17% | -3.90% | +3.82% | +47.52% | +87.34% | +365.85% | +1,326.00% | 99TCr | |
| -0.29% | -3.51% | +2.22% | +11.43% | +28.33% | +48.78% | +63.27% | +59.06% | +124.63% | 64TCr | |
| +0.83% | +0.26% | +2.81% | +14.39% | +12.53% | +16.76% | +72.52% | +141.02% | +305.81% | 45TCr | |
| -0.38% | -3.59% | -6.70% | +5.81% | +4.88% | +28.24% | +35.57% | +0.06% | +43.42% | 34TCr | |
| -0.09% | -13.54% | -10.98% | -7.82% | +2.23% | +10.08% | +26.87% | +42.42% | +44.75% | 26TCr | |
| -1.34% | -13.70% | -8.92% | +6.58% | +15.29% | +33.47% | +44.18% | +76.54% | +126.57% | 20TCr | |
| -3.44% | -7.51% | -10.01% | -2.16% | -15.00% | -20.08% | -59.58% | -11.89% | +86.73% | 19TCr | |
| -0.75% | -4.82% | +5.86% | +14.18% | +17.09% | +21.94% | +86.55% | +102.45% | +84.14% | 18TCr | |
| +0.25% | -2.57% | +4.13% | +5.92% | +11.33% | +11.50% | -18.33% | -39.20% | -18.71% | 16TCr | |
| +0.17% | -5.62% | -2.68% | +15.82% | +13.69% | +29.71% | +48.45% | +173.34% | +450.21% | 13TCr | |
| -0.17% | -4.76% | +0.05% | +11.85% | +17.98% | +33.87% | +4.65% | +0.81% | +14.34% | 13TCr | |
| -0.42% | -3.93% | -2.84% | -3.98% | -11.44% | -9.26% | -28.05% | -10.52% | +4.14% | 10TCr | |
| -0.28% | -4.12% | -6.62% | -9.78% | -2.96% | +16.67% | +20.54% | -0.23% | -11.45% | 9.59TCr | |
| +0.06% | -5.49% | -9.70% | -13.54% | -22.09% | -3.37% | +43.44% | +53.82% | +462.51% | 6.88TCr | |
| +0.16% | -1.51% | +1.50% | +12.58% | +17.19% | +25.80% | +24.66% | +51.05% | +20.30% | 5.89TCr | |
| -1.09% | -1.39% | -1.59% | +34.59% | +30.15% | +67.08% | -5.92% | +5.23% | -49.31% | 5.49TCr | |
| +2.04% | +2.01% | +1.67% | +7.32% | +18.84% | +86.48% | +269.42% | +303.59% | -26.13% | 4.32TCr | |
| -0.61% | -7.28% | -22.38% | -9.17% | -28.37% | -37.52% | -0.77% | -10.07% | +166.26% | 4.19TCr | |
| -0.71% | -5.39% | -8.65% | -0.06% | -10.94% | -8.32% | +2.77% | - | - | 3.98TCr | |
| Average | -0.33% | -4.76% | -4.11% | +3.81% | +4.37% | +19.86% | +36.45% | +70.87% | +173.53% | 22.14TCr | |
| Weighted average by Cap. | -0.39% | -4.32% | -3.61% | +3.34% | +7.74% | +27.60% | +48.38% | +126.27% | +398.57% |
- Stock Market
- Stocks
- AZN Stock
- Sector AstraZeneca PLC
Select your edition
All financial news and data tailored to specific country editions
